The Autorité de la concurrence imposes a fine of 25 million euros on Janssen-Cilag laboratory and its parent company Johnson & Johnson for having first prevented then restricted the development of generic versions of Durogesic, its originator medicinal product.

14 December 2016: Sector-wide Inquiry on Hearing Aids- the Autorité's Findings

Print the page

Decision of

Decision 16-D-23 of 24 October 2016 regarding practices in the sector of prosthetic or dental implant pose by dental surgeons

Presentation of the decision

Information about the decision


Print the page
Print the page

26 April 2016: Draft orders/on-line sales of medicinal products

Print the page
Print the page
Subscribe to Healthcare